申请人:SYNBLIA THERAPEUTICS, INC.
公开号:US20200385370A1
公开(公告)日:2020-12-10
Compounds of Formula I as IRAK4 inhibitors are disclosed. The pharmaceutical compositions comprising compounds of formula I, methods of synthesis of these compounds, methods of treatment for diseases associated with IRAK-4 such as inflammatory diseases and autoimmune diseases using these compounds or compositions containing these compounds are also disclosed.